Biweekly episodes will feature researchers, clinicians, industry representatives, and innovators discussing how focused ultrasound could change medicine.
In the first episode Foundation Chairman Neal Kassell, MD, shares his journey and the origins of the Foundation.
While EDAP’s Focal One platform already has FDA clearance to treat the prostate, recent results indicate it is also effective for rectal endometriosis.
The FDA’s Breakthrough Devices Program allows fast-tracking of certain novel devices and expedites patient access to treatments.
A recent review article outlines the state of the field, current challenges, and barriers to clinical translation for focused ultrasound–mediated gene delivery in the brain.
Gene therapy has the potential to treat many neurodegenerative diseases, as has already been proven in at least two of them.
The Advanced Research Projects Agency for Health (ARPA-H) Sprint for Women’s Health program will commit $100 million to fund transformative research and development in women's health.
Interested researchers can submit applications for funding through April 15.
Jessica Foley, PhD, recently visited the Virginia House of Delegates to share the groundbreaking focused ultrasound research taking place in the state.
She also advocated for continued state funding for focused ultrasound research at the University of Virginia and Virginia Tech.
“It’s all about the patients. The beating heart of the Foundation is the commitment of all the people here to the philosophy that the highest calling in life is helping other people.”
‒ Chairman Neal F. Kassell, MD, on the first episode of the Curing with Sound podcast